Serum NFL and neuropsychological performance over ∼8 years in women with and without HIV: a longitudinal repeated measures study
- PMID: 39911246
- PMCID: PMC11794164
- DOI: 10.1016/j.eclinm.2024.103052
Serum NFL and neuropsychological performance over ∼8 years in women with and without HIV: a longitudinal repeated measures study
Abstract
Background: Blood-based biomarkers of Alzheimer's disease (AD) and stroke, including serum neurofilament light chain (sNFL), are understudied in women living with and without HIV.
Methods: We assessed cross-sectional and longitudinal change in sNFL between 2008 and 2019 associated with neuropsychological performance (NP) among women living with HIV (WLWH) and without HIV (WLWOH) age ≥40 years in the Women's Interagency HIV Study. Baseline and repeated ∼8-year fasting sNFL levels were measured using Simoa. Sociodemographically-adjusted NP T-scores (attention, working memory, executive function, processing speed, learning, verbal fluency and global) were calculated. Multivariable linear regression analyses stratified by HIV serostatus examined cross-sectional baseline and follow-up associations, and ∼8-year change in sNFL level related to global and domain-specific NP T-scores.
Findings: 417 participants (290 WLWH, 127 WLWOH), African American/Black (55%), ≥high school education (69%), current/former smokers (79%), and overweight/obese (BMI ≥25.0 kg/m2, 74%) were included. Compared to WLWOH at baseline, WLWH performed worse on memory and global NP. WLWH versus WLWOH had higher baseline (p ≤ 0.001) and follow-up median (p < 0.0001) sNFL levels and ∼8-year change (46.5% in WLWH versus 24.4% in WLWOH, p < 0.0001). Among WLWH, higher baseline sNFL was associated with poorer processing speed, learning, memory and verbal fluency. Among WLWOH, higher baseline sNFL was associated with poorer executive function, processing speed and verbal fluency. Among WLWH, higher follow-up sNFL was associated with poorer executive function. Among WLWOH, higher follow-up sNFL was associated with poorer executive function, processing speed, attention, memory, and global NP. ∼8-year increase in sNFL occurred in both WLWH and WLWOH and was associated with poorer executive function, processing speed, memory, and global performance at follow-up among WLWOH, and poorer executive function in WLWH. Adjustment for multiple comparisons showed associations at cross-sectional follow-up and ∼8-year increase in sNFL in WLWOH, only. Higher sNFL was associated with poorer baseline processing speed in WLWH only.
Interpretation: Higher levels and greater ∼8-year increases in sNFL were associated with poorer NP by domain in WLWH and WLWOH differentially over time.
Funding: The contents of this publication are solely the responsibility of the authors and do not represent the official views of the National Institutes of Health (NIH). MACS/WIHS Combined Cohort Study (MWCCS) (Principal Investigators: Bronx CRS (Kathryn Anastos, David Hanna, and Anjali Sharma), U01-HL146204; Brooklyn CRS (Deborah Gustafson and Tracey Wilson), U01-HL146202; Data Analysis and Coordination Center (Gypsyamber D'Souza, Stephen Gange and Elizabeth Topper), U01-HL146193; Chicago-Cook County CRS (Mardge Cohen and Audrey French), U01-HL146245; Northern California CRS (Bradley Aouizerat, Jennifer Price, and Phyllis Tien), U01-HL146242; Metropolitan Washington CRS (Seble Kassaye and Daniel Merenstein), U01-HL146205. The MWCCS is funded primarily by the National Heart, Lung, and Blood Institute (NHLBI), with additional co-funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute on Aging (NIA), National Institute of Dental and Craniofacial Research (NIDCR), National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Neurological Disorders and Stroke (NINDS), National Institute of Mental Health (NIMH), National Institute on Drug Abuse (NIDA), National Institute of Nursing Research (NINR), National Cancer Institute (NCI), National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institute on Deafness and Other Communication Disorders (NIDCD), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute on Minority Health and Health Disparities (NIMHD), and in coordination and alignment with the research priorities of the National Institutes of Health, Office of AIDS Research (OAR). MWCCS data collection is also supported by UL1-TR000004 (UCSF CTSA), UL1-TR003098 (JHU ICTR), UL1-TR001881 (UCLA CTSI).
Keywords: Cognition; HIV; Neurofilament light chain; Neuropsychological performance; Women.
© 2025 The Authors.
Conflict of interest statement
HZ is a Wallenberg Scholar and a Distinguished Professor at the Swedish Research Council supported by grants from the Swedish Research Council (#2023-00356; #2022-01018 and #2019-02397), the European Union's Horizon Europe research and innovation programme under grant agreement No 101053962, and Swedish State Support for Clinical Research (#ALFGBG-71320). KB is supported by the Swedish Research Council (#2017-00915 and #2022-00732), the Swedish Alzheimer Foundation (#AF-930351, #AF-939721, #AF-968270, and #AF-994551), Hjärnfonden, Sweden (#FO2017-0243 and #ALZ2022-0006), the Swedish state under the agreement between the Swedish government and the County Councils, the ALF-agreement (#ALFGBG-715986 and #ALFGBG-965240). HZ has also served at scientific advisory boards and/or as a consultant for Abbvie, Acumen, Alector, Alzinova, ALZPath, Amylyx, Annexon, Apellis, Artery Therapeutics, AZ Therapies, Cognito Therapeutics, CogRx, Denali, Eisai, Merry Life, Nervgen, Novo Nordisk, Optoceutics, Passage Bio, Pinteon Therapeutics, Prothena, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave, has given lectures in symposia sponsored by Alzecure, Biogen, Cellectricon, Fujirebio, Lilly, and Roche, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the Gothenburg University's Ventures Incubator Program (outside submitted work). PM has received speaking honoraria from Mayo Clinic, Healthy Women, InfectionIQ; from Bayer, International Menopause Society for travel to a meeting; Astellas, Bayer for advisory board services and consultation; and has equity with Estrigenix, Respin, and MidiHealth. KM is a board member for the Hektoen Institute of Medicine Board Member.
Figures
Similar articles
-
Plasma Biomarkers of Alzheimer Disease in Women With and Without HIV.JAMA Netw Open. 2023 Nov 1;6(11):e2344194. doi: 10.1001/jamanetworkopen.2023.44194. JAMA Netw Open. 2023. PMID: 38019518 Free PMC article.
-
Midlife body mass index, central adiposity and neuropsychological performance over 10 years in women living with and without HIV.Front Endocrinol (Lausanne). 2023 Jul 7;14:1108313. doi: 10.3389/fendo.2023.1108313. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37484940 Free PMC article.
-
Body Mass Index and Leptin Are Related to Cognitive Performance Over 10 Years in Women With and Without HIV Infection.J Clin Endocrinol Metab. 2022 Feb 17;107(3):e1126-e1135. doi: 10.1210/clinem/dgab759. J Clin Endocrinol Metab. 2022. PMID: 34677589 Free PMC article.
-
Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.Clin Ther. 2008 Sep;30(9):1565-89. doi: 10.1016/j.clinthera.2008.09.014. Clin Ther. 2008. PMID: 18840365 Review.
-
Aging and Neurocognitive Functioning in HIV-Infected Women: a Review of the Literature Involving the Women's Interagency HIV Study.Curr HIV/AIDS Rep. 2016 Dec;13(6):399-411. doi: 10.1007/s11904-016-0340-x. Curr HIV/AIDS Rep. 2016. PMID: 27730446 Free PMC article. Review.
References
-
- Khalil M., Teunissen C.E., Lehmann S., et al. Neurofilaments as biomarkers in neurological disorders - towards clinical application. Nat Rev Neurol. 2024;20(5):269–287. - PubMed
-
- 2023 Alzheimer's disease facts and figures. Alzheimers Dement. 2023;19(4):1598–1695. - PubMed
-
- World Health Organization The top 10 causes of death. 2019. https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-de...
-
- Virani S.S., Alonso A., Aparicio H.J., et al. Heart disease and stroke statistics-2021 update: a report from the American Heart association. Circulation. 2021;143(8):e254–e743. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous